iBio, Inc. (IBIO) Insider Trading Disclosures
iBio, Inc. (IBIO) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: IBIO
CIK: 1420720
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grassi & Co., CPAs, P.C.
Auditor SinceSince 6/30/2024 12:00:00 AM
Lead Engagement PartnerMatthew Lombardo
Audit LocationJericho, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-15 | 2026-10-14 | OWNERSHIP DOCUMENT | 0001104659-26-116322 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-14 | OWNERSHIP DOCUMENT | 0001104659-26-116321 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-14 | OWNERSHIP DOCUMENT | 0001104659-26-116320 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-14 | OWNERSHIP DOCUMENT | 0001104659-26-116319 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-14 | OWNERSHIP DOCUMENT | 0001104659-26-116318 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-14 | OWNERSHIP DOCUMENT | 0001104659-26-116317 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-14 | — | SCHEDULE 13G Filing | 0001104659-26-115801 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-13 | 8-K | 0001420720-26-000030 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001420720-26-000028 | View SEC Doc Filr Page |
| ARS | 2026-09-04 | 2026-06-30 | ARS | 0001420720-26-000025 | View SEC Doc Filr Page |
| DEF 14A | 2026-09-04 | 2026-09-04 | DEF 14A | 0001420720-26-000022 | View SEC Doc Filr Page |
| 10-K | 2026-08-28 | 2026-06-30 | 10-K | 0001420720-26-000020 | View SEC Doc Filr Page |
| 8-K | 2026-08-28 | 2026-08-28 | 8-K | 0001420720-26-000019 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-20 | 2026-10-14 | PRE 14A | 0001420720-26-000016 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000902664-26-003523 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000902664-26-003494 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003690 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001011438-26-000508 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | OWNERSHIP DOCUMENT | 0001104659-26-090344 | View SEC Doc Filr Page |
| 3 | 2026-08-04 | 2026-07-31 | OWNERSHIP DOCUMENT | 0001104659-26-090061 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-07-31 | 8-K | 0001420720-26-000014 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-17 | 8-K | 0001420720-26-000012 | View SEC Doc Filr Page |
| 8-K | 2026-07-01 | 2026-07-01 | 8-K | 0001420720-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-05-19 | 2026-05-18 | OWNERSHIP DOCUMENT | 0001104659-26-063503 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000935836-26-000283 | View SEC Doc Filr Page |